First Time Loading...

Beijing Strong Biotechnologies Inc
SZSE:300406

Watchlist Manager
Beijing Strong Biotechnologies Inc Logo
Beijing Strong Biotechnologies Inc
SZSE:300406
Watchlist
Price: 18.49 CNY 4.17% Market Closed
Updated: Apr 29, 2024

Beijing Strong Biotechnologies Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Strong Biotechnologies Inc
Operating Income Peer Comparison

Comparables:
6160
1801
603392
S
002252
300122

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Strong Biotechnologies Inc
SZSE:300406
Operating Income
¥618.5m
CAGR 3-Years
59%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Income
-¥12B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
-¥1.1B
CAGR 3-Years
-36%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
¥1.4B
CAGR 3-Years
22%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Operating Income
¥2B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
22%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
¥9.9B
CAGR 3-Years
38%
CAGR 5-Years
46%
CAGR 10-Years
47%

See Also

What is Beijing Strong Biotechnologies Inc's Operating Income?
Operating Income
618.5m CNY

Based on the financial report for Dec 31, 2023, Beijing Strong Biotechnologies Inc's Operating Income amounts to 618.5m CNY.

What is Beijing Strong Biotechnologies Inc's Operating Income growth rate?
Operating Income CAGR 5Y
13%

Over the last year, the Operating Income growth was 26%. The average annual Operating Income growth rates for Beijing Strong Biotechnologies Inc have been 59% over the past three years , 13% over the past five years .